New paradigms for BRCA1/BRCA2 testing in women with ovarian cancer: results of the Genetic Testing in Epithelial Ovarian Cancer (GTEOC) study

BACKGROUND: Over recent years genetic testing for germline mutations in BRCA1/BRCA2 has become more readily available because of technological advances and reducing costs. OBJECTIVE: To explore the feasibility and acceptability of offering genetic testing to all women recently diagnosed with epithel...

Descripción completa

Detalles Bibliográficos
Autores principales: Plaskocinska, Inga, Shipman, Hannah, Drummond, James, Thompson, Edward, Buchanan, Vanessa, Newcombe, Barbara, Hodgkin, Charlotte, Barter, Elisa, Ridley, Paul, Ng, Rita, Miller, Suzanne, Dann, Adela, Licence, Victoria, Webb, Hayley, Tan, Li Tee, Daly, Margaret, Ayers, Sarah, Rufford, Barnaby, Earl, Helena, Parkinson, Christine, Duncan, Timothy, Jimenez-Linan, Mercedes, Sagoo, Gurdeep S, Abbs, Stephen, Hulbert-Williams, Nicholas, Pharoah, Paul, Crawford, Robin, Brenton, James D, Tischkowitz, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Cancer Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099175/
https://www.ncbi.nlm.nih.gov/pubmed/27208206
http://dx.doi.org/10.1136/jmedgenet-2016-103902

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099175/
https://www.ncbi.nlm.nih.gov/pubmed/27208206
http://dx.doi.org/10.1136/jmedgenet-2016-103902

Ejemplares similares